Amber Therapeutics
PrivateLast Round
Series A
Jun 10, 2024
Total Funding Raised
$100M
Company Overview
Amber Therapeutics is a biotechnology company that develops innovative bioelectronic platforms for closed-loop therapies aimed at treating mixed urinary incontinence through targeted peripheral interventions.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Amber Therapeutics Comparables
Compare Amber Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Juniper Biomedical | 85% | |
| BlueWind Medical | 83% | |
| Neuspera Medical | 80% | |
Amber Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 10, 2024 | ||||
| Seed | Jan 24, 2023 |
Amber Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| New Enterprise Associates (NEA) | Series A |
| Lightstone Ventures | Series A |
| Oxford Science Enterprises | Series A, Seed |
| F-Prime Capital | Series A |
| UKRI Innovate UK | Seed |
| Intuitive Ventures | Series A |
| Oxford Science Enterprises | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 1, 2025
Accelerating towards first Pivotal Trial for Picostim System.
- Jun 10, 2024
$100M round led by New Enterprise Associates (NEA)
Amber Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Amber Therapeutics's valuation, stock price, and market status.